Anebulo Pharmaceuticals, Inc. ( (ANEB) ) has released its Q1 earnings. Here is a breakdown of the information Anebulo Pharmaceuticals, Inc.

Revenue of $6.3 million and $18.8 million for the three- and nine-month period ending September 30, 2024, representing a 0.34 ...

President-elect Donald Trump's decision to nominate controversial Republican Matt Gaetz for the post of attorney general has stunned GOP senators, leading to expectations that Gaetz won't actually get ...

Medical, a division of Tilray Brands, announced the launch of its first commercial German grown medical cannabis flowers from its ...

Speaking of medical product, the one bright spot in the 2024 election is that, of the two votes that passed in Nebraska, one ...

Cannabis stocks are in focus today, with most of the action centered around U.S.-based multi-state operators (MSOs) after ...

A reality check around regulatory challenges facing the cannabis sector has taken hold among some of the leading financiers ...

The 2024 US election results weren’t great for cannabis, leading to double-digit sector stock drops. Vice President Kamala Harris, who had stated intentions to legalize recreational use nationally, ...

Aurora Cannabis sees 29% YoY growth and solid cash flow, unaffected by U.S. market fears. Read why ACB stock remains a solid ...

Florida's failed adult-use cannabis vote led to a $2.6B loss in market cap. Was the market reaction justified? Earnings data adds uncertainty.

Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) today announces its financial results ...